Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VitaPhore is a medical device company focused on developing a novel antimicrobial platform to prevent catheter-related infections. Founded by serial entrepreneur Dr. John Simpson, the company addresses the critical issue of biofilm formation on indwelling medical devices, which is a primary cause of hospital-acquired infections. The VitaPhore technology integrates antimicrobial agents into catheters to provide sustained protection against a broad spectrum of pathogens. Their initial product pipeline includes antimicrobial versions of central venous catheters, PICC lines, and hemodialysis catheters. By reducing infection rates, VitaPhore aims to improve patient safety and decrease the significant healthcare costs associated with complications from vascular access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VitaPhore.